Professor Puig
Professor Puig
Director of the Department of Dermatology. Hospital de la Santa Creu i Sant Pau and Professor of Dermatology at the Universitat Autònoma de Barcelona, Barcelona, Spain.
During the past 14 years, Professor Puig’s clinical research has focussed on the treatment of psoriasis with biological agents. He is considered to be a key opinion leader in this field, both nationally and internationally, having taught at numerous national and international conferences, workshops and seminars, and provided advice to several pharmaceutical companies. He has authored several book chapters and numerous papers in indexed journals (h index = 42, i10 index = 187). He is a member of the Editorial Board of Dermatology and other Dermatology journals.
He is a member of several national and international scientific societies, including AEDV, CILAD, EADV, AAD, ASDP, GRAPPA and ESDR. He is currently a Member of the Board of Directors of the EADV (2013–, in representation of the Spanish members), Co-chair of the Psoriasis Task Force of the EADV, Councillor of the International Psoriasis Council (2012–), President (2016–) of the Scientific Board of the Psoriasis International Network and the Fondation René Touraine (2008–), Member of the European Dermatology Forum (2017–), Board Member of the International Psoriasis Council (2018–), and Vice president of the Administration Council of the Fondation René Touraine (2018–).
of interest
are looking at
saved
next event
The Psoriasis Management, Psoriasis Treatment and Psoriasis Guidelines content has been developed by EPG Health for Medthority. This content has been developed independently of the sponsor Almirall S.A, who have had no editorial input into the content. EPG Health received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
The Expert Opinion and PsoMOT content has been developed by EPG Health for Medthority in collaboration with the sponsor Almirall S.A., utilising content from their Almirall funded symposium at EADV 2021 and PsoMOT meeting in November 2019.